The Status of the Standard of Care for Cancer Patients

Alex A. Adjei, MD, PhD, FACP

Video Categories: Personalized Medicine

Dr. Alex Adjei discusses how the standard of care for cancer patients has improved overt he last few years, but there is still a great need for new treatments designed to help a broader range of cancer patients.
October 1, 2018

How International Standards for Molecular Biomarker Testing in Lung Cancer Have Influenced Which Tests are Routinely Performed

Drs. Roy Herbst and David Rimm discuss the 50-gene panel that has become an ISLC-mandated standard for all patients with lung cancer; however, the components of cancer biomarker testing panels must be fluid and respond to new developments in the field as reported in the literature and/or at international cancer [ Read More ]

October 1, 2014

Defining the Role of Pharmacists in Polycythemia Vera

Atheer Kaddis presents the role of the pharmacist with regards to polycythemia vera and describes why it is unique.Supported through funding from Incyte